Arbutus Biopharm (ABUS)
$3.46
0.04 (1.16%)
Arbutus Layoffs 2024: What to Know About the Latest ABUS Job Cuts
While the Arbutus layoffs represents a major overhaul operationally, the market has responded positively to ABUS stock. Here’s why.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$3.27
Market Cap
670.18M
PE Ratio
-9.18
EPS
-0.3768
Volume (Avg. Vol.)
1.44M
Day's Range
$3.26 - $3.54
52-Week Range
$2.30 - $4.73
Dividend & Yield
N/A (N/A)